Have scientists found the key to beating prostate cancer?

Have scientists found the key to beating prostate cancer? ‘Miracle’ immunotherapy trial targets protein that allows tumours to flourish Prostate cancer is the most common cancer in men with 48,500 cases a year Researchers start clinical trials on a protein which may be key to treating them The goal is to unleash cancer-killing white blood … Read more

Have scientists found the key to beating prostate cancer?

Have scientists found the key to beating prostate cancer? ‘Miracle’ immunotherapy trial targets protein that allows tumours to flourish Prostate cancer is the most common cancer in men with 48,500 cases a year Researchers start clinical trials on a protein which may be key to treating them The goal is to unleash cancer-killing white blood … Read more

DIY home testing kit that diagnoses prostate cancer trialled in Britain 

DIY home testing kit that diagnoses prostate cancer trialled in Britain Researchers will post kits to 2,000 men in this country, Europe and Canada  Men who could benefit from the test include those with low-risk prostate cancer  They could be seen less frequently – potentially only every two or three years By Victoria Allen Science … Read more

DIY home testing kit that diagnoses prostate cancer trialled in Britain 

DIY home testing kit that diagnoses prostate cancer trialled in Britain Researchers will post kits to 2,000 men in this country, Europe and Canada  Men who could benefit from the test include those with low-risk prostate cancer  They could be seen less frequently – potentially only every two or three years By Victoria Allen Science … Read more

New urine test could detect aggressive form of prostate cancer missed by as many as 1 in 5 scans 

New urine test could detect aggressive form of prostate cancer often missed by as many as one in five diagnostic scans The University of Michigan Rogel Cancer Center has developed a new test called Urine Prostate Seq test (UPSeq) It analyzes 15 specific strands of RNA together and looks for specific genes that are ‘overexpressed’ … Read more

Oxford researchers say tool to detect risk of prostate cancer can help GPs prioritise patients 

Calculator that adds up risk of prostate cancer: Oxford researchers say online tool can help GPs prioritise high-risk patients Researchers at Oxford University say their online tool can help GPs It is designed to tell men their personal risk of developing prostate cancer It is more accurate than the existing prostate specific antigen (PSA) test … Read more

YouTube star Mark ‘Angry Dad’ Orval, 53, gives update on his ‘aggressive’ prostate cancer

Retired Australian rules footballer Mark Orval, known around the world as YouTube sensation ‘Angry Dad’, announced ‘aggressive’ prostate cancer diagnosis last week. And on Thursday, the father of three, 53, gave a heartbreaking update on his health battle on Channel Nine’s Today show, with his wife Sharon by his side. The lovable larrikin spoke candidly … Read more

YouTube star Mark ‘Angry Dad’ Orval is diagnosed with ‘aggressive’ prostate cancer

Retired Australian rules footballer Mark Orval, known around the world as YouTube sensation ‘Angry Dad’, has been diagnosed with ‘aggressive’ prostate cancer. The father of three, 53, who recently lost his own mother to cancer, received his diagnosis from a specialist after a blood test several weeks ago ‘concerned’ his GP. He announced the news with … Read more

Prostate cancer drug is found to be an effective antiviral against coronavirus and the common cold

An experimental cancer drug derived from a poisonous plant could stop Covid-19 in its tracks, researchers believe.  Nottingham University academics claim thapsigargin should be effective against the coronavirus behind the pandemic and others that cause common colds. The drug, derived from the ‘deadly carrot’ thapsia plant — which is deadly to cattle and sheep and … Read more

Thousands of men with prostate cancer will be denied life-extending drug

Thousands of men with prostate cancer will be denied life-extending drug after health experts ruled it was not cost effective Life-extending drug for advanced prostate cancer patients was not approved  Abiraterone gives patients extra 15 months on average and cuts the risk of them dying within three years by a third Institute which approves NHS drugs ruled … Read more